Pharmaceutical manufacturers are finding significant cost savings by migrating from expensive SQL Server licenses to PostgreSQL without compromising compliance or performance.
According to AmpleLogic’s whitepaper, SQL Server Enterprise Edition costs approximately $13,748 per core, while Standard Edition costs around $3,586 per core. For medium to large pharmaceutical operations requiring multiple servers, these costs multiply rapidly. Beyond licensing fees, companies face additional costs for software assurance, specialized IT personnel, infrastructure upgrades, and third-party tools.
One of the largest vaccination manufacturing companies partnered with AmpleLogic to address this challenge. The company’s eLogbook system, a critical digital platform used to maintain electronic logs, was burdened by high licensing fees, limited scalability, and vendor lock-in.
AmpleLogic proposed migrating the eLogbook application to PostgreSQL on Linux. The whitepaper details how this open-source database technology eliminates licensing fees while delivering enterprise-grade performance. PostgreSQL offers advanced clustering and replication features for efficient handling of high data volumes, robust security controls that support industry compliance standards, and remarkable flexibility for integration with diverse applications.
The results were compelling. After the migration, the vaccine manufacturer achieved –
– 70% drop in database costs
– Faster system performance
– Higher uptime and reliability
A comparative analysis between Windows Server with SQL Server versus Linux Ubuntu with PostgreSQL reveals stark differences. While the Microsoft stack demands high licensing fees and resource consumption, the Linux/PostgreSQL combination offers minimal licensing costs, built-in clustering capabilities, industry-standard security, and optimized resource efficiency.
The whitepaper highlights how the vaccine manufacturer was able to redirect funds toward R&D and digital transformation initiatives. The company also gained improved scalability and system reliability, enabling better resource allocation and pharmaceutical IT budget optimization.
For pharmaceutical IT directors facing budget constraints, PostgreSQL migration represents a strategic opportunity. The approach is not just about cost-cutting; it’s about creating a more adaptable infrastructure that can evolve alongside changing business needs while maintaining strict regulatory compliance.
With AmpleLogic’s expertise in server migration, operational transition, and compliance maintenance, pharmaceutical companies can implement this cost-saving strategy without compromising on the industry’s stringent regulatory requirements. Their specialized knowledge in PostgreSQL migration enables a smooth transition that maintains data integrity for audit trails and GMP adherence.
Smart Pharma IT does not require compromise. With the right expertise guiding the transition, companies can achieve the seemingly impossible trifecta: secure, scalable, and cost-efficient database infrastructure.
For further such informative articles, you can visit – https://amplelogic.com/
AmpleLogic | GAMP Solutions | aPaaS for Life Sciences
– C Wing, 2nd Floor, Melange Tower, Huda Techno Enclave Rd, Patrika Nagar, HITEC City, Hyderabad, Telangana 500081
Press Contact – 7396660171
Email Address – marketing@amplelogic.com
Amplelogic offers 14 powerful SaaS products on our advanced aPaaS platform, providing pre-configured, compliant solutions while enabling custom app development. Our Low Code/No Code capabilities allow life sciences companies to easily tailor applications without needing extensive technical expertise. All solutions comply with global regulatory standards like the US FDA and MHRA, ensuring compliance while fostering innovation.
This release was published on openPR.
